|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: SPART |
Gene summary for SPART |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | SPART | Gene ID | 23111 |
| Gene name | spartin | |
| Gene Alias | SPG20 | |
| Cytomap | 13q13.3 | |
| Gene Type | protein-coding | GO ID | GO:0000902 | UniProtAcc | A0A024RDV9 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 23111 | SPART | AEH-subject1 | Human | Endometrium | AEH | 4.01e-09 | 2.24e-01 | -0.3059 |
| 23111 | SPART | AEH-subject2 | Human | Endometrium | AEH | 4.40e-03 | 1.27e-01 | -0.2525 |
| 23111 | SPART | AEH-subject3 | Human | Endometrium | AEH | 1.88e-08 | 2.08e-01 | -0.2576 |
| 23111 | SPART | AEH-subject4 | Human | Endometrium | AEH | 1.15e-13 | 3.66e-01 | -0.2657 |
| 23111 | SPART | AEH-subject5 | Human | Endometrium | AEH | 1.85e-09 | 2.34e-01 | -0.2953 |
| 23111 | SPART | EEC-subject1 | Human | Endometrium | EEC | 1.69e-11 | 2.50e-01 | -0.2682 |
| 23111 | SPART | EEC-subject2 | Human | Endometrium | EEC | 1.88e-08 | 2.12e-01 | -0.2607 |
| 23111 | SPART | EEC-subject3 | Human | Endometrium | EEC | 3.99e-06 | 1.95e-01 | -0.2525 |
| 23111 | SPART | EEC-subject4 | Human | Endometrium | EEC | 1.88e-08 | 2.07e-01 | -0.2571 |
| 23111 | SPART | EEC-subject5 | Human | Endometrium | EEC | 3.48e-12 | 2.27e-01 | -0.249 |
| 23111 | SPART | GSM5276934 | Human | Endometrium | EEC | 1.16e-34 | 5.68e-01 | -0.0913 |
| 23111 | SPART | GSM5276935 | Human | Endometrium | EEC | 4.35e-17 | 2.66e-01 | -0.123 |
| 23111 | SPART | GSM5276937 | Human | Endometrium | EEC | 9.78e-36 | 5.59e-01 | -0.0897 |
| 23111 | SPART | GSM6177620_NYU_UCEC1_lib1_lib1 | Human | Endometrium | EEC | 4.55e-02 | 1.76e-01 | -0.1869 |
| 23111 | SPART | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 8.15e-11 | 3.39e-01 | -0.1934 |
| 23111 | SPART | male-WTA | Human | Thyroid | PTC | 5.13e-22 | 3.34e-01 | 0.1037 |
| 23111 | SPART | female-WTA | Human | Thyroid | PTC | 2.08e-02 | 2.44e-01 | 0.0726 |
| 23111 | SPART | nodule-WTA | Human | Thyroid | goiters | 6.09e-09 | 3.47e-01 | 0.0534 |
| 23111 | SPART | PTC01 | Human | Thyroid | PTC | 2.90e-24 | 3.92e-01 | 0.1899 |
| 23111 | SPART | PTC03 | Human | Thyroid | PTC | 6.13e-09 | 4.03e-01 | 0.1784 |
| Page: 1 2 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Endometrium |  | AEH: Atypical endometrial hyperplasia |
| EEC: Endometrioid Cancer | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:00507677 | Endometrium | AEH | regulation of neurogenesis | 56/2100 | 364/18723 | 8.87e-03 | 4.82e-02 | 56 |
| GO:006156412 | Endometrium | EEC | axon development | 93/2168 | 467/18723 | 9.60e-08 | 4.69e-06 | 93 |
| GO:005188114 | Endometrium | EEC | regulation of mitochondrial membrane potential | 26/2168 | 74/18723 | 9.77e-08 | 4.73e-06 | 26 |
| GO:001604915 | Endometrium | EEC | cell growth | 95/2168 | 482/18723 | 1.16e-07 | 5.54e-06 | 95 |
| GO:003253516 | Endometrium | EEC | regulation of cellular component size | 79/2168 | 383/18723 | 1.98e-07 | 8.93e-06 | 79 |
| GO:006056013 | Endometrium | EEC | developmental growth involved in morphogenesis | 54/2168 | 234/18723 | 4.60e-07 | 1.78e-05 | 54 |
| GO:000740912 | Endometrium | EEC | axonogenesis | 82/2168 | 418/18723 | 1.03e-06 | 3.49e-05 | 82 |
| GO:000155814 | Endometrium | EEC | regulation of cell growth | 77/2168 | 414/18723 | 1.64e-05 | 3.16e-04 | 77 |
| GO:000717814 | Endometrium | EEC | transmembrane receptor protein serine/threonine kinase signaling pathway | 68/2168 | 355/18723 | 1.90e-05 | 3.50e-04 | 68 |
| GO:004858813 | Endometrium | EEC | developmental cell growth | 49/2168 | 234/18723 | 2.59e-05 | 4.56e-04 | 49 |
| GO:001097513 | Endometrium | EEC | regulation of neuron projection development | 79/2168 | 445/18723 | 6.80e-05 | 1.01e-03 | 79 |
| GO:000836111 | Endometrium | EEC | regulation of cell size | 39/2168 | 181/18723 | 8.72e-05 | 1.24e-03 | 39 |
| GO:004592611 | Endometrium | EEC | negative regulation of growth | 48/2168 | 249/18723 | 2.58e-04 | 2.98e-03 | 48 |
| GO:003050911 | Endometrium | EEC | BMP signaling pathway | 32/2168 | 152/18723 | 5.52e-04 | 5.52e-03 | 32 |
| GO:004863812 | Endometrium | EEC | regulation of developmental growth | 58/2168 | 330/18723 | 7.65e-04 | 7.16e-03 | 58 |
| GO:00303081 | Endometrium | EEC | negative regulation of cell growth | 37/2168 | 188/18723 | 8.33e-04 | 7.67e-03 | 37 |
| GO:007177211 | Endometrium | EEC | response to BMP | 33/2168 | 165/18723 | 1.16e-03 | 9.90e-03 | 33 |
| GO:007177311 | Endometrium | EEC | cellular response to BMP stimulus | 33/2168 | 165/18723 | 1.16e-03 | 9.90e-03 | 33 |
| GO:006138711 | Endometrium | EEC | regulation of extent of cell growth | 24/2168 | 110/18723 | 1.55e-03 | 1.24e-02 | 24 |
| GO:00614481 | Endometrium | EEC | connective tissue development | 44/2168 | 252/18723 | 3.51e-03 | 2.36e-02 | 44 |
| Page: 1 2 3 4 5 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| hsa0414420 | Endometrium | AEH | Endocytosis | 56/1197 | 251/8465 | 2.58e-04 | 2.15e-03 | 1.57e-03 | 56 |
| hsa04144110 | Endometrium | AEH | Endocytosis | 56/1197 | 251/8465 | 2.58e-04 | 2.15e-03 | 1.57e-03 | 56 |
| hsa0414424 | Endometrium | EEC | Endocytosis | 57/1237 | 251/8465 | 3.34e-04 | 2.82e-03 | 2.10e-03 | 57 |
| hsa0414434 | Endometrium | EEC | Endocytosis | 57/1237 | 251/8465 | 3.34e-04 | 2.82e-03 | 2.10e-03 | 57 |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |